Home > Insider Trading > Filing (0001127602-17-014315)

Filing Details

Accession Number:: 0001127602-17-014315
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-05 16:04:26
Reporting Period:: 2017-04-03

Filing Date:: 2017-04-05
Accepted Time:: 2017-04-05 16:04:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1156039	Anthem Inc.	ANTM	Hospital & Medical Service Plans (6324)	352145715

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1203671	M Gloria Mccarthy	120 Monument Circle Indianapolis IN 46204	Evp & Chief Transformation Off	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-04-03	14,271	$89.44	59,144	No	4	M	Direct
Common Stock	Disposition	2017-04-03	7,471	$165.81	51,673	No	4	S	Direct
Common Stock	Disposition	2017-04-03	7,416	$166.91	44,257	No	4	S	Direct
Common Stock	Disposition	2017-04-03	300	$167.45	43,957	No	4	S	Direct
Common Stock	Acquisiton	2017-04-03	1,127	$0.00	45,084	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2017-04-03	14,271	$0.00	14,271	$89.44
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2017-04-03	4,606	$0.00	4,606	$166.97

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-03-03	No	4	M	Direct
4,606		2027-04-03	No	4	A	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017.
This transaction was executed in multiple trades at prices ranging from $165.43 to $166.41. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide uponrequest to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $166.44 to $167.42. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide uponrequest to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $167.44 to $167.47 The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff,the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Represents restricted share units. Restrictions lapse as follows: 375 shares on 4/3/2018 and, 376 shares each on 4/3/2019 and 4/3/2020.
The option, represents a right to purchase a total of 25,671 shares, and is exercisable in six semi-annual installments, with three installments of 4,278 shares each and three installments of 4,279 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date.
The option represents a right to purchase a total of 4,606 shares, and is exercisable in six semi-annual installments, with two installments of 767 shares each and four installments of 768 shares each, beginning on October 3, 2017, which is the six-month anniversary of the option grant date.